EGFR and IL-6R signaling cross-talk through JAK2/STAT3 to mediate EMT in ovarian carcinomas; activated STAT3 in high-grade ovarian carcinomas may occur directly through activation of EGFR/IL-6R or indirectly through induction of IL-6R signaling (76). This evidence concerns the gene JAK2 and ovarian carcinoma.